Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
Open Access
- 30 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 10 (10), e1004485
- https://doi.org/10.1371/journal.ppat.1004485
Abstract
The anti-tuberculosis-vaccine Bacillus Calmette-Guérin (BCG) is the most widely used vaccine in the world. In addition to its effects against tuberculosis, BCG vaccination also induces non-specific beneficial effects against certain forms of malignancy and against infections with unrelated pathogens. It has been recently proposed that the non-specific effects of BCG are mediated through epigenetic reprogramming of monocytes, a process called trained immunity. In the present study we demonstrate that autophagy contributes to trained immunity induced by BCG. Pharmacologic inhibition of autophagy blocked trained immunity induced in vitro by stimuli such as β–glucans or BCG. Single nucleotide polymorphisms (SNPs) in the autophagy genes ATG2B (rs3759601) and ATG5 (rs2245214) influenced both the in vitro and in vivo training effect of BCG upon restimulation with unrelated bacterial or fungal stimuli. Furthermore, pharmacologic or genetic inhibition of autophagy blocked epigenetic reprogramming of monocytes at the level of H3K4 trimethylation. Finally, we demonstrate that rs3759601 in ATG2B correlates with progression and recurrence of bladder cancer after BCG intravesical instillation therapy. These findings identify a key role of autophagy for the nonspecific protective effects of BCG. Next to its effects against tuberculosis, BCG vaccination also induces non-specific beneficial effects on immune cells to increase their ability to control unrelated pathogens. It has been recently proposed that the non-specific effects of BCG are mediated through epigenetic reprogramming of monocytes, a process called trained immunity. Little is known regarding the intracellular events controlling its induction. In this study we identified autophagy as a key player in trained immunity. Pharmacological inhibition of autophagy as well as polymorphisms in autophagy-related genes blocked BCG-induced trained immunity. Furthermore, BCG vaccine is also used to treat bladder cancer. Genetic polymorphisms in autophagy-related genes correlated with progression and recurrence of bladder cancer after treatment with BCG therapy. These findings open new possibilities for improvement of future BCG-based vaccines to be used against infections and malignancies.Keywords
This publication has 29 references indexed in Scilit:
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences of the United States of America, 2012
- Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of MonocytesCell Host & Microbe, 2012
- Polymorphisms in Autophagy Genes and Susceptibility to TuberculosisPLOS ONE, 2012
- Small Randomized Trial Among Low–birth-weight Children Receiving Bacillus Calmette-Guérin Vaccination at First Health Center ContactThe Pediatric Infectious Disease Journal, 2012
- Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid dropletsMolecular Biology of the Cell, 2012
- European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility geneHuman Molecular Genetics, 2011
- Adaptive immune features of natural killer cellsNature, 2009
- A Specific Primed Immune Response in Drosophila Is Dependent on PhagocytesPLoS Pathogens, 2007
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- BCG vaccination of Indian infants in Saskatchewan: A study carried out with financial assistance from the National Research Council of CanadaTubercle, 1949